SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Biosyn Themis informs about voting results & scrutinizer’s report

15 Oct 2024 Evaluate

Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Biosyn Themis has informed that it enclosed: a) Voting Results of the business transacted by the Company by way of Postal Ballot Notice dated 10th September, 2024. b) Scrutinizer’s Report dated 14th October, 2024. The resolution as proposed in the Postal Ballot Notice has been passed by the shareholders by remote e-voting process with requisite majority i.e. 99.99% The Voting Results along with the Scrutinizer’s Report is also available on the Company’s website at https://www.gtbl.in/.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

90.00 -0.25 (-0.28%)
20-Apr-2026 11:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1238.10
Cipla 1239.20
Zydus Lifesciences 942.70
Lupin 2325.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×